Koninklijke Philips (AMS:PHIA) received a €31.10 ($38.40) price target from equities research analysts at Morgan Stanley in a report issued on Monday. The brokerage currently has a “neutral” rating on the stock. Morgan Stanley’s price objective would suggest a potential downside of 0.92% from the stock’s current price.
PHIA has been the subject of a number of other research reports. JPMorgan Chase & Co. set a €36.80 ($45.43) target price on Koninklijke Philips and gave the stock a “neutral” rating in a report on Friday, November 10th. Credit Suisse Group set a €37.00 ($45.68) price target on Koninklijke Philips and gave the company a “buy” rating in a research report on Wednesday, January 31st. Berenberg Bank set a €34.00 ($41.98) price target on Koninklijke Philips and gave the company a “neutral” rating in a research report on Monday, October 23rd. BNP Paribas set a €35.00 ($43.21) price target on Koninklijke Philips and gave the company a “neutral” rating in a research report on Tuesday, October 24th. Finally, Barclays set a €33.00 ($40.74) price target on Koninklijke Philips and gave the company a “neutral” rating in a research report on Wednesday, January 31st. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of €35.31 ($43.60).
Koninklijke Philips (AMS:PHIA) traded down €0.60 ($0.74) during trading on Monday, hitting €31.39 ($38.75). The company had a trading volume of 4,070,000 shares, compared to its average volume of 2,980,000. Koninklijke Philips has a 12-month low of €26.90 ($33.21) and a 12-month high of €36.12 ($44.59). The firm has a market capitalization of $29,530.00 and a P/E ratio of 32.36.
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.